Avistar Communications got a letter from the Nasdaq stock market last week telling the company that it is back in compliance with the rule requiring companies it lists to have a minimum stock price of $1 a share.
Its share price shot back above $1 back in June Read the rest of this entry »
Not that this is a shock, but Genitope, the beleaguered biotech that warned in May that it had only enough cash to continue operations through June 2008 and that it would be laying off all of its employees save its CEO, was told by Nasdaq that its shares would be delisted from its market next Monday, according to a press release it issued today. Worse, Nasdaq also “advised” Genitope that Read the rest of this entry »
NeoMagic, which has dealt with multiple delisting threats from the Nasdaq stock market over the last few years for various reasons — including a stock price below $1, insufficient shareholder equity, and delinquent filings — has a new problem to deal with: not enough independent directors on either its board of directors or its audit committee.
NeoMagic received notice of the possible delisting from Nasdaq July 8 following resignations the month before of Read the rest of this entry »
Proxim Wireless reported in a filing today that it was “advised” last Friday by its accountants, Fitzgerald, Snyder & Co., that it was resigning. The reason? It seems that the “engagement” partner at the firm who handles Proxim’s account, is leaving. Proxim also announced that it hired a new accounting firm, Mark Bailey & Co., with which, Proxim says neither it nor anyone on its behalf consulted over the last two-and-a-half years.
We wondered whether Read the rest of this entry »
Focus Enhancements, the Campbell maker of tools for digital video systems, has received a letter from the Nasdaq Stock Market notifying the company that its market value has fallen below the minimum amount the Nasdaq requires for continued listing. It was given until July 16 to try and bring that value up.
As of June 13, according to the Nasdaq letter, Focus Enhancement was valued by investors at Read the rest of this entry »
Subscribe via RSS all feeds